Podcasts about Colorectal cancer

At 57, Ronnie was living a healthy, active life as a health coach, marathon runner, and triathlete. She had always taken great care of her health and never imagined that cancer would be part of her story—until June of 2018 after a routine colonoscopy, Ronnie was diagnosed with stage 4 colon cancer that had spread to liver, lungs, peritoneum and lymph nodes.   Faced with this grim prognosis, she chose to take an active role in her treatment. Ronnie opted for traditional chemotherapy but also incorporated naturopathic treatments into her regimen. Ronnie believed this combination would help support her body during the chemotherapy and aid in her healing. The journey wasn't easy, but the balance of conventional medicine and natural therapies helped her to stay strong and cope with the challenges she faced. Looking back, Ronnie realizes that her success wasn't just the result of traditional treatments or naturopathic therapies—it was her mindset, resilience, and refusal to give up. Cancer tried to take her life, but instead, it gave her a new one, one filled with gratitude, strength, and a deeper understanding of what truly matters. To learn more about Ronnie and her work visit, https://ronniecampbellauthor.com/ To purchase her book, Racing for a Miracle: A Stage 4 Survivor's Journey of Hope. Celebrating 5 Years Cancer-Free—A Story of Strength, Early Detection, and Miracles, visit https://ronniecampbellauthor.com/about-the-book/ Instagram @ronniecampbellauthor.com (https://www.instagram.com/ronniecampbell.author/) Facebook @ronnieswellness4life.com ( https://www.facebook.com/profile.php?id=100083650758740  )  Learn more about Colorectal Cancer Canada at https://www.colorectalcancercanada.com/ _________ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com. To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram YouTube _____ Thank you to our friends from The Healing Oasis for sponsoring this episode of the podcast.  The Healing Oasis is a first of its kind in beautiful British Columbia, Canada where we encourage the body to heal from cancer using alternative therapies & cancer fighting meals at a wellness retreat center in nature. Our top naturopathic cancer doctor will prescribe a protocol tailored specifically for you. There's no place quite like it. Start your healing journey today! Learn More about The Healing Oasis by visiting these links: Website   Testimonials Video Overview

Can Gut Health in Childhood Help Prevent Bowel Cancer Later in Life?This week on the podcast, we're talking about something that might feel a little confronting but also incredibly empowering: how our kids' health today could shape their future health tomorrow.Bowel cancer rates are on the rise in young people, and new research is pointing to a surprising contributor — one we've been talking about for a long time here at Natural Super Kids: gut health. In this episode, we will break down what this means for parents without fear, but with practical action in mind.Here's what we cover:What the latest research says about childhood gut bacteria and bowel cancer risk.How early-life factors like C-section births, antibiotics, and diet can impact long-term gut health.Subtle signs that your child's gut may be out of balance — from tummy troubles to mood changes.Easy, gut-supportive changes you can start making right now (even if life feels busy).

Featuring perspectives from Dr Christopher Lieu and Dr Kanwal Raghav, including the following topics: Optimizing the Care of Patients with Nonmetastatic Colorectal Cancer (CRC) — Dr Lieu (0:00) Recent Advances in the Management of Metastatic CRC — Dr Raghav (32:58) CME information and select publications

Clinical investigators discuss available data guiding the management of colorectal cancer.  CME information and select publications here.

Clinical investigators discuss available data guiding the management of colorectal cancer.  CME information and select publications here.

Chloe E. Atreya, MD, PhD / Marwan Fakih, MD - Focusing on the Patient in Front of Us: Expert Perspectives on Providing Patient-Centered Care for Refractory Metastatic Colorectal Cancer

Is minimally invasive ablation the future of metastatic cancer care? We now have the results of the COLLISION Trial, which investigates the non-inferiority of thermal ablation compared to surgical resection. How will these findings change treatment paradigms and practice patterns around metastatic colorectal cancer? In this week's episode of BackTable, interventional radiologist Dr. Chris Beck discusses the impact and implications of the COLLISION Trial with principal investigator Dr. Martijn Meijerink from Amsterdam UMC.---SYNPOSISThe doctors explore the COLLISION Trial's design, results, complication rates, and future directions. They also cover best practices for ablation techniques and the potential for interventional oncology to enter a “golden era.” Finally, Dr. Meijerink highlights the importance of standardizing intervention quality and being present in tumor boards to ensure optimal patient care.---TIMESTAMPS00:00 - Introduction 03:21 - Understanding Metastatic Colorectal Cancer and IR's Role05:18 - Introduction to the COLLISION Trial07:40 - Radiofrequency vs Microwave Ablation and Technological Advancements09:02 - Trial Design and Patient Eligibility16:20 - Ablation Techniques and Approaches22:05 - Trial Results and Analysis30:19 - Impact on Guidelines and Practice39:44 - Best Practices in Thermal Ablation43:27 - Future Directions in Interventional Oncology---RESOURCES“Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial.” (Meijerink, 2024)https://ascopubs.org/doi/10.1200/JCO.2024.42.17_suppl.LBA3501

A recent #study from Assiut University Hospital in Egypt, published in #Oncotarget, presents a promising strategy for patients with metastatic #colorectalcancer (mCRC). The #research introduces a gentler yet effective maintenance therapy that may extend survival, enhance quality of life, and offer a more accessible treatment option for mCRC patients worldwide. The Challenge of Treating Metastatic Colorectal Cancer Colorectal cancer is one of the most common causes of cancer-related deaths worldwide. When it spreads to other parts of the body—a stage known as mCRC—it becomes much more difficult to treat. At this stage, clinicians often use strong drug combinations like FOLFOX or CAPOX, which mix chemotherapy drugs to stop cancer growth. FOLFOX combines three drugs given intravenously, while CAPOX includes two of the same drugs, with one taken as a pill. While effective, these treatments can cause serious side effects. For example, one of the main drugs, oxaliplatin, can lead to nerve damage, making it painful or difficult to use the hands and feet. Fatigue, diarrhea, and other issues are also common. Over time, these side effects may force clinicians to stop or adjust the treatment, even if it is working. That is where maintenance therapy comes in. After the cancer is controlled, clinicians often switch to a gentler treatment plan to keep it from returning. The challenge is finding a therapy that continues to work without causing too many side effects, especially in places where access to expensive or intensive treatments is limited. Full blog - https://www.oncotarget.org/2025/05/07/panitumumab-and-low-dose-capecitabine-a-promising-maintenance-therapy-for-metastatic-colorectal-cancer/ Paper DOI - https://doi.org/10.18632/oncotarget.28687 Correspondence to - Doaa A. Gamal - doaaalygamaal@gmail.com Video short - https://www.youtube.com/watch?v=wuPSS0EdK-8 Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28687 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, Panitumumab, maintenance, colorectal cancer, Capecitabine About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

In this episode of The Patient From Hell, host Samira Daswani speaks with Dr. Sara Char about her journey into oncology, the evolution of cancer biology, and the significant role of the microbiome in colon cancer. They discuss the complexities of cancer survivorship, the effectiveness of different methods of delivering survivorship care plans, and the importance of colonoscopy in monitoring colorectal cancer. The conversation also delves into the impact of diet on cancer risk, emphasizing the need for a comprehensive understanding of dietary patterns rather than focusing solely on individual foods. In this conversation, Dr. Sara Char discusses various aspects of survivorship care for colorectal cancer patients, focusing on dietary recommendations, exercise, and the emotional challenges faced during the transition from active treatment to survivorship. The dialogue emphasizes the importance of balancing nutrition, understanding the role of GLP-1 agonists, and the need for a supportive care team. Additionally, the conversation highlights the unique mental health needs of survivors and the significance of providing patients with a roadmap for their cancer journey.About Our Guest:Dr. Sara Char is a hematology and oncology fellow at Dana-Farber Cancer Institute. She specializes in the care of patients with gastrointestinal cancers with a specific interest in young-onset colorectal cancer. Her research explores the molecular underpinnings of diet and lifestyle factors implicated in colorectal cancer development and progression. Dr. Char received her M.D. from Tufts University School of Medicine and completed her residency training in internal medicine at Massachusetts General Hospital, where she also served as chief resident. Outside of work, she is a self-identified foodie and devoted dog-mom. Resources & Links:This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features the PCORI research study here: https://pubmed.ncbi.nlm.nih.gov/34302474/ - ‘Simplifying Survivorship Care Planning: A Randomized Controlled Trial Comparing 3 Care Plan Delivery Approaches'Chapter Codes00:00 Exploring the Microbiome and Colon Cancer05:59 The Transition to Survivorship Care11:57 Understanding Adherence in Survivorship Plans17:49 The Role of Colonoscopy in Survivorship24:06 Dietary Patterns and Cancer Risk25:04 Inflammatory Diet and Health Outcomes28:11 Dietary Recommendations for Cancer Survivors30:34 Exercise and Body Composition in Cancer Care31:59 Managing GI Issues with GLP-1 Agonists34:43 Navigating Multidisciplinary Care35:50 The Transition from Active Treatment to Survivorship38:08 Mental Health Challenges Post-Treatment41:41 The Need for Psycho-Oncology Support46:47 The Importance of Patient Education and ResourcesConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Disclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute.

In this episode, Dr. Tejas Jayakrishnan discusses the rising incidence of young onset colorectal cancer (CRC) and the potential environmental factors contributing to this trend. The conversation delves into the importance of screening protocols, the challenges faced in early detection, and the role of education in increasing awareness and understanding of cancer risks. Dr. Jayakrishnan emphasizes the need for tailored approaches in patient care, particularly for younger patients, and highlights ongoing research efforts aimed at improving outcomes in this demographic.About Our Guest:Dr. Thejus Jayakrishnan is a gastrointestinal medical oncologist at Dana-Farber Cancer Institute and Brigham and Women's Hospital, and an Instructor in Medicine at Harvard Medical School. Originally from India, he completed his medical training in New Delhi and continued his journey through residency in Pittsburgh and oncology fellowship at Cleveland Clinic.Dr. Jayakrishnan's research explores why some people develop cancers like colorectal cancers at a younger age. He studies how metabolism, gut bacteria, and genetics contribute to these patterns, with the goal of developing better tools for screening and treatment.In the clinic, he treats patients with all types of gastrointestinal cancers and works closely with Dana-Farber's Young-Onset Colorectal Cancer Center. His focus is on translating scientific discoveries into meaningful improvements in care through clinical trials. Outside of work, he's an avid cyclist, outdoor enthusiast, and lover of books and movies.Resources & Links:This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features the PCORI research study here: https://pubmed.ncbi.nlm.nih.gov/30578103/ - ‘Impact of including quantitative information in a decision aid for colorectal cancer screening: A randomized controlled trial'Chapter Codes:00:00 - Understanding Young Onset Colorectal Cancer10:03 - Screening Protocols and Challenges19:50 - The Role of Education in Cancer Awareness30:04 - Future Directions in Colorectal Cancer ResearchConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @MantaCares and visit our website at MantaCares.com for more episodes and updates.Disclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute. 

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-429 Overview: Colorectal cancer screening saves lives, yet many patients remain unscreened. This episode explores current screening methods, the evidence behind the new DNA blood test, and how it compares to existing options. Gain practical insights to guide patient discussions and improve screening rates in your practice. Episode resource links: N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714 N Engl J Med 2024;390:984-93. DOI: 10.1056/NEJMoa2310336 Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com   

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-429 Overview: Colorectal cancer screening saves lives, yet many patients remain unscreened. This episode explores current screening methods, the evidence behind the new DNA blood test, and how it compares to existing options. Gain practical insights to guide patient discussions and improve screening rates in your practice. Episode resource links: N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714 N Engl J Med 2024;390:984-93. DOI: 10.1056/NEJMoa2310336 Guest: Jillian Joseph, MPAS, PA-C Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com   

Dustin A. Deming, MD - Personalizing Treatment Pathways for Refractory Metastatic Colorectal Cancer: Informed Decision-Making When Disease Has Progressed

Dustin A. Deming, MD - Personalizing Treatment Pathways for Refractory Metastatic Colorectal Cancer: Informed Decision-Making When Disease Has Progressed

Dustin A. Deming, MD - Personalizing Treatment Pathways for Refractory Metastatic Colorectal Cancer: Informed Decision-Making When Disease Has Progressed

Dustin A. Deming, MD - Personalizing Treatment Pathways for Refractory Metastatic Colorectal Cancer: Informed Decision-Making When Disease Has Progressed

CT colonography (CTC) is now at an inflection point following recent regulatory updates. In this AJR Conversation, Gastrointestinal Imaging Section Editor Federica Vernuccio, MD, PhD, speaks with David Kim, MD, about his team's recently published article on the use of CTC for colorectal cancer prevention and detection.

In this episode, host Jonathan Sackier speaks with Alexander Spira about cutting-edge advances in lung and colorectal cancer, including EGFR and KRAS-targeted therapies. They also discuss Spira's leadership in oncology research, his thoughts on the evolving ‘town-gown' dynamic in US medicine, and his hopes for the future of cancer care.  Timestamps:  00:00 – Introduction 01:50 – Most memorable family travel adventure 03:30 – What inspired you to go into oncology 05:49 – Three recent publications in lung cancer 07:02 – Real-world data on colorectal cancer 08:15 – Sex/gender differences in non-small cell lung cancer 11:53 – The science of KRAS mutations and drug development 15:07 – Accelerating diagnostics and access to therapies 17:13 – The ‘town-gown' debate in American healthcare 18:09- Three Wishes 

- Overview of Colorectal Cancer - Current Standard of Care - The Increasing Number of Younger People Being Diagnosed with Colorectal Cancer - New Treatment Approaches - Predicting Response to Treatment - Staging & Biomarker Testing - The Role of Targeted Cancer Therapies - Clinical Trial Updates: How Research Contributes to Treatment Options - Preventing & Managing Treatment Side Effects, Symptoms, Discomfort & Pain - Nutrition & Hydration Concerns & Tips - Communicating with Your Health Care Team About Quality-of-Life Concerns & Follow-Up Appointments - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions for Our Panel of Experts

- Overview of Colorectal Cancer - Current Standard of Care - The Increasing Number of Younger People Being Diagnosed with Colorectal Cancer - New Treatment Approaches - Predicting Response to Treatment - Staging & Biomarker Testing - The Role of Targeted Cancer Therapies - Clinical Trial Updates: How Research Contributes to Treatment Options - Preventing & Managing Treatment Side Effects, Symptoms, Discomfort & Pain - Nutrition & Hydration Concerns & Tips - Communicating with Your Health Care Team About Quality-of-Life Concerns & Follow-Up Appointments - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions for Our Panel of Experts

Morgan had not turned 45 yet, so she hadn't received a screening colonoscopy for colorectal cancer. But when she noticed blood in her stool at age 41, she did exactly what she should have and sought medical evaluation. After months of missteps became years of dismissive care, she realized it was time for a second opinion at Siteman Cancer Center. With the help of WashU Medicine radiation oncologist Hyun Kim, MD, co-director of the Young-Onset Colorectal Cancer Program, Morgan was given a treatment plan that provided the care she needed. In this episode, we discuss her persistence and dedication to getting herself the best care for her young-onset colorectal cancer diagnosis.   “This is Cancer” is brought to you by Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, and produced at Spot Content Studio in St. Louis, MO.   For more information on topics discussed in this episode, go to: https://siteman.wustl.edu/treatment/cancer-types/colorectal/young-onset-colorectal-cancer-program/ https://siteman.wustl.edu/treatment/cancer-types/colorectal/prevention-and-screening/  https://siteman.wustl.edu/doctor/kim-hyun/ https://getscreenednow.com/colon-cancer/ https://getscreenednow.com/insurance/  

Dr. Roby breaks down the facts, shares the latest screening options, and explains how local resources are making screenings more accessible than ever. Whether you're 45 or approaching it, this conversation could save your life—or the life of someone you love.Listen now at KMOJFM.com or wherever you stream KMOJ.#ColorectalCancerAwareness #KMOJHealth #GetScreenedMN #FreddieBell #HennepinHealthcare #BlackHealthMatters

March is National Colorectal Cancer Awareness Month. In this B-Side episode, we dive into everything you need to know about the disease.Colorectal cancer is the fourth leading cause of cancer-related deaths in the Philippines, with an estimated one in 1,800 Filipinos at risk each year. To help understand its symptoms, treatments, and prevention, Dr. Dave Rennel L. Sebollena, Vice President of the Philippine Society of Gastroenterology, joins the conversation.We also explore the financial and healthcare support available for patients with Dr. Israel Francis A. Pargas, Senior Vice President for the Health Finance Sector and Spokesperson of PhilHealth.Interview by Edg Adrian EvaAudio editing by Jayson Mariñas

Ask your smart speaker to "Play One Oh Three One Austin"

For this special episode of the Astonishing Healthcare podcast, Andrew Barnell, CEO of Geneoscopy, joins Justin Venneri in the studio for an insightful discussion about colorectal cancer (CRC) screening in observance of National CRC Awareness Month! Andrew explains how he and his "very talented" sister, Erica Barnell, MD, PhD, co-founded Geneoscopy to develop diagnostic tests using RNA biomarkers extracted from stool samples. Their newly FDA-approved test, ColoSense™, provides a non-invasive alternative to traditional colonoscopies.Barnell highlights the rising incidence of CRC in younger adults, which prompted guideline changes to lower the recommended screening age to 45. He stresses the urgent need for increased screening awareness and greater access to screening tools, noting that employers can help overcome barriers to screening through education and by encouraging engagement in wellness programs. Other topics covered include:Over 135,000 people are diagnosed with CRC every year, and despite CRC being one of the most preventable cancers with good long-term survival rates following treatment, 50,000 people die from it annually. Preventive screenings are increasingly covered with no patient out-of-pocket costs, but insurers' expenses are rising.Increasing early screening is crucial: 30-40% of eligible individuals remain unscreened, particularly in the 45-49 age group.Geneoscopy's decentralized clinical trial and overall use of technology to conduct its pivotal FDA approval study virtually, which increased patient diversity and efficiency.Regulatory challenges remain: FDA approval is just one step; Medicare coverage and guideline inclusion are key hurdles.Bringing targeted therapy approaches to autoimmune diseases like IBD to improve patient outcomes and reduce costs is Geneoscopy's next goal.Related ContentMultitarget Stool RNA Test for Colorectal Cancer Screening. Barnell EK, Wurtzler EM, La Rocca J, et al. JAMA. 2023;330(18):1760–1768. doi:10.1001/jama.2023.22231Pharmacogenomics (PGx) 101: What You Need to Know for Rx ProgramsReference Materials/Other Links (courtesy of Geneoscopy)Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer. Ladabaum U, Mannalithara A, Schoen RE, Dominitz JA, Lieberman D. Ann Intern Med. 2024 Dec;177(12):1610-1620. doi: 10.7326/ANNALS-24-00910. Epub 2024 Oct 29. PMID: 39467291.Colorectal Cancer—Patient Version. National Cancer Institute (NCI)Productivity savings from colorectal cancer prevention and control strategies. Bradley CJ, Lansdorp-Vogelaar I, Yabroff KR, Dahman B, Mariotto A, Feuer EJ, Brown ML. Am J Prev Med. 2011 Aug;41(2):e5-e14. doi: 10.1016/j.amepre.2011.04.008. PMID: 21767717; PMCID: PMC3139918.Follow Geneoscopy on LinkedInFor more information about Capital Rx and this episode, please visit Capital Rx Insights.

This isn't your father's colonoscopy. Colorectal screening is entering a new era, with innovations that make the process easier, detection earlier and more accessible than ever. From a simple blood test that can detect signs of cancer to AI technology helping doctors catch polyps that might otherwise go unnoticed, today's tools are transforming the screening experience. Whether you're due for your first test or curious about your options, this conversation offers the insight you need to take charge of your colorectal health — with clarity, confidence and peace of mind.Host:Sandra PeeblesAward-Winning JournalistExperts:Victor Maciel, M.D., Colorectal Surgeon at Baptist HealthAriel Sims, M.D., Gastroenterologist at Gastro Health

In this powerful episode, we share a deeply personal story about the devastating impact of early-onset colorectal cancer—and the urgent need for better screening. Our guest, Dr. George Beauregard, is an internal medicine physician and healthcare executive whose world changed forever in 2017 when his newly married 29-year-old son was diagnosed with stage 4 colorectal cancer—just a month after his wedding. Through his son's courageous fight and advocacy, Dr. Beauregard found a renewed purpose: raising awareness about the alarming rise in early-onset cases and the need for improved screening and research. He also shares insights from his memoir, Reservations For Nine: A Doctor's Family Confronts Cancer, blending his personal and professional perspectives. Join us as we discuss his son's lasting legacy, the emotional and medical lessons from their journey, and the fight for earlier detection. This conversation is a call to action for greater awareness, earlier intervention, and meaningful change.  

In this episode of The Real GI Doc Show, Dr. Gandolfo takes a moment to highlight an important guest appearance he made on The Positive Gene Podcast, hosted by cancer previvor and cancer prevention advocate Sara Kavanaugh, in honor of Colorectal Cancer Awareness Month. What is a "previvor" you may ask? A previvor is a survivor of a predisposition for cancer or another disease. In Sara's case that condition is Lynch Syndrome-the most common hereditary cancer predisposition syndrome. With colorectal cancer being the fourth most commonly diagnosed cancer and the second leading cause of cancer death in the United States, Dr. Gandolfo emphasizes the urgency of discussing this critical topic. During the episode, Dr. Gandolfo and Sara delve into various aspects of colorectal cancer, including: - The significance of understanding Lynch Syndrome, a genetic condition that increases the risk of several cancers, including colorectal cancer. - Preventative measures through diet and lifestyle that can help reduce the risk of colorectal cancer. - The concerning rise of colon cancer diagnoses among younger individuals and what symptoms to watch for. - The importance of timely screening and colonoscopy, especially for those with risk factors, regardless of age. Listeners will gain valuable insights into colorectal cancer prevention, the role of genetics in cancer risk, and practical advice for discussing symptoms and screening with healthcare providers. Tune into The Positive Gene Podcast to listen to the full 58-minute interview using the links below: Listen on Apple: https://podcasts.apple.com/us/podcast/the-positive-gene-podcast/id1708990295?i=1000699080929 Listen on Spotify: https://open.spotify.com/episode/53zke5DCLEehnLLLcM2x5P?si=c93068d7a1c549e8 Visit The Positive Gene Podcast page for all other ways to listen: https://thepositivegenepodcast.podbean.com/ Follow Sara Kavanaugh on Instagram https://www.instagram.com/positivegenepodcast/ --- Watch The Real GI Doc Show on YouTube! Click here! Be sure to subscribe to The Real GI Doc Show for more insights, and reach out with your questions on social media @realgidoc or leave an audio question for Dr. Gandolfo here. Find The Real GI Doc Show on social media, join the newsletter, read Dr. Gandolfo's bio, or ask a question using this link.  

Join us for a powerful episode of Cancer Awareness and Healing with Kaumudi Bhawe, Founder & Principal at YOM Consulting Services, as we shine a light on Colorectal Cancer Awareness & Healing. Learn about early warning signs, risk factors, the importance of screening, and the latest advancements in treatment. Discover how awareness and lifestyle changes can play a crucial role in prevention and healing. Don't miss this informative and inspiring conversation on Spotify and Apple Podcast only on TALRadio English.Host : MadhaviGuest : Kaumudi BhaweYou Can Reach Kaumudi @linkedin.com/in/kaumudi-bhawe-ph-d-7a8114b#TALRadioEnglish #ColorectalCancerAwareness #CancerHealing #KaumudiBhawe #CancerPrevention #HealthAwareness #CancerSupport #WellnessJourney #EarlyDetection #CancerResearch #EmpowermentThroughKnowledge #HealthMatters #TouchALife #TALRadio #TALPodcast

In this episode, we highlight a panel of medical experts and community leaders in Ashland County who are sounding the alarm about rising colorectal cancer rates. You’ll hear insights on why local screening rates don’t match the area’s high mortality numbers, a survivor’s powerful call to action, and how environmental factors might be playing a role. Read the full story: https://www.ashlandsource.com/2025/03/19/expert-panel-discusses-colorectal-cancer-rates-in-ashland-county/ Support the show: https://richlandsource.com/membersSee omnystudio.com/listener for privacy information.

In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Sebastian Stintzing, Head of Department of Medicine, Division of Hematology, Oncology, and Cancer Immunology, Charité - Universitäetsmedizin Berlin, Germany. They discuss the most promising developments in gastrointestinal oncology, with particular focus on the role of personalised medicine in metastatic colorectal cancer treatment.  Timestamps:    00:00 – Introduction  03:04 – Impactful developments in gastrointestinal oncology  08:53 – Issues with funding clinical trials  14:17 – Designing trials and the importance of patient advocacy   17:11 – Translational biomarker programs  19:58 – Treatment strategies for RAS wild-type tumours  22:28 – The FIRE-4.5 study on mutant metastatic colorectal cancer  29:50 – Genetic profiling and epigenomics  33:12 – Precision medicine and immune oncology in GI cancers  34:52 – Colorectal cancer in younger adults  34:54 – Raising awareness for early screening of GI cancers 

Colorectal cancer is one of the most preventable cancers—when caught early. Yet, screening rates remain too low, and cases in younger adults are rising at an alarming rate. Disparities in access to screening also put certain communities at higher risk, making awareness and early detection more critical than ever. In this episode, we're joined by Dr. Reezwana Chowdhury, a leading gastroenterologist at Johns Hopkins and Chair of the American College of Gastroenterology's (ACG) Public Relations Committee. She's also a dedicated advocate for improving awareness in the South Asian community through her work with the South Asian IBD Alliance (SAIA). We cover: Who should get screened and when The rise in early-onset colorectal cancer The connection between IBD and colorectal cancer risk How screening can save your life This episode is presented in collaboration with the American College of Gastroenterology's Patient Care Committee.  

As the Gut Doctor podcast continues to raise awareness for colorectal cancer, Dr. Parikh interviews Dr. Paul Limburg, MD, who is a gastroenterologist and chief medical officer for Exact Sciences. They discuss colon cancer prevalence, barriers to CRC screening, and the role of stool based testing such as Cologuard. This episode is sponsored by Exact Sciences whose purpose is to help eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment. Exact Sciences is the maker of the Cologuard® test, a stool-based screening test for average risk adults ages 45 and over. 

Honoring National Colon Cancer Awareness Month & National Nutrition Month! In this episode, we take note of the fact that March is National Colon Cancer Awareness Month. Importance of Nutrition to our Well-being and the importance of being aware of the factors that can impact on our good health. Over the last 40 years, the rates of certain cancers, especially the GI cancers like Colorectal Cancer, Pancreatic Cancer and Stomach Cancer are being diagnosed in those less than 50. Today, we discuss some of the factors that may be contributing as well as what we can do to reduce any risk to our family., especially our children. watch here: https://youtu.be/M2kbJ8yn-cU

Honoring National Colon Cancer Awareness Month & National Nutrition Month! In this episode, we take note of the fact that March is National Colon Cancer Awareness Month. Importance of Nutrition to our Well-being and the importance of being aware of the factors that can impact on our good health. Over the last 40 years, the rates of certain cancers, especially the GI cancers like Colorectal Cancer, Pancreatic Cancer and Stomach Cancer are being diagnosed in those less than 50. Today, we discuss some of the factors that may be contributing as well as what we can do to reduce any risk to our family., especially our children. watch here: https://youtu.be/M2kbJ8yn-cU

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston and Dr Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston summarize the most clinically relevant research findings and data presented over the past year for patients with colorectal cancer. CME information and select publications here.

Featuring perspectives from Dr Scott Kopetz and Dr Jeffrey Meyerhardt, including the following topics: Introduction (0:00) Cell-Free DNA Molecular Residual Disease Assays in Clinical Practice (3:25) Immunotherapy for Localized and Metastatic Microsatellite Instability-High Colorectal Cancer (28:27) Other Important Datasets (46:06) CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer | Faculty Presentation 2: Advances in the Management of Metastatic CRC (mCRC) — Scott Kopetz, MD, PhD CME information and select publications

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston and Dr Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston summarize the most clinically relevant research findings and data presented over the past year for patients with colorectal cancer. CME information and select publications here.

Negotiations are underway in the Mississippi legislature over the state's income tax--whether to cut or not to cut.Then, A school choice bill that would have allowed students to easily move between public school districts has died on the House calendar. Plus, More Mississippians die of colorectal cancer than anywhere else in the nation. Health officials are stressing the importance of prevention and early detection. Hosted on Acast. See acast.com/privacy for more information.

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer | Faculty Presentation 1: Optimizing the Care of Patients with Localized Colorectal Cancer (CRC) — Jeffrey Meyerhardt, MD, MPH CME information and select publications

In this episode of We Talk Health Podcast, we discuss Kirkland Cancer Center's Colorectal Cancer Screenings for March. March is Colorectal Cancer Awareness Month, and we are sitting down with some folks from Kirkland Cancer Center to talk all about our upcoming screenings in partnership with Cologuard, what is involved in the journey and more.Colorectal Cancer is the third most common cancer in the world, which means screening and early detection are vital! Guest:Elizabeth VickeryMarketing & Community Outreach Manager | Kirkland Cancer CenterRene HamptonGI Nurse NavigatorAbby MaysClinical Dietitian | Kirkland Cancer CenterHost:Kara MobleySocial Media CoordinatorResources:Podcast Show Notes

An inside look into how the iconic hit, “We are the World,” came to be. Also, new details on groundbreaking research that's being done to help find cancer before it spreads. And, Regé-Jean Page talks being a secret agent in his new thriller, “Black Bag.” 

A growing number of young people in Canada are being diagnosed with colorectal cancer, and their needs often differ from older patients. Melissa Grof​f was diagnosed at age 34, with three small kids, in the prime of her career.​​ ​She​ says she would have benefitted from more age-appropriate care. Sunnybrook's Young Adult Colorectal Cancer Clinic offers this care including support for mental health, sexual health, body image issues and family planning.

To protect against colorectal cancer, women should be sure to get enough calcium from…

Colorectal cancer is the second leading cause of cancer deaths in the U.S. and, alarmingly, rates are rising in younger adults. On this 20-Minute Health Talk, Marc Greenwald, MD, discusses risk factors, symptoms, treatments and the importance of early screening. He also addresses common concerns about colonoscopy, from advances in prep to the lifesaving procedure itself, and helps listeners understand the importance of being proactive about their health.    About the expert Dr. Greenwald is chief of colorectal clinical services; surgeon-in-chief; and director of the rectal cancer program at North Shore University Hospital. About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

This week on Health Matters, Courtney Allison is joined by Dr. Alessandro Fichera, chief of colon and rectal surgery at NewYork-Presbyterian and Weill Cornell Medicine. They discuss the recent rise of colorectal cancer in people under 50, and explore what might be one reason behind it—the eating habits of the typical Western diet.Dr. Fichera offers health tips for lowering cancer risk. It turns out, there are simple steps we could all take to give our hard-working guts the support they need. From eating more natural fiber to staying hydrated, Dr. Fichera explains some surprising links between the choices we make about our lifestyle and the risk of colorectal cancer.___Dr. Alessandro Fichera is Chief of the Division of Colon and Rectal Surgery at NewYork-Presbyterian and Weill Cornell Medicine. Dr. Alessandro Fichera received his medical degree from Catholic University of Rome, Italy in 1989. Since then, he has studied, practiced, and taught colorectal surgery across the United States: taking prestigious positions and leading departments of surgery in Chicago, Seattle, Dallas, and beyond. He serves on the ASCRS Executive Council and the Crohn's and Colitis Foundation National Scientific Advisory Committee.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

Screenings for colorectal cancer are very effective and save lives. “Since we started doing colonoscopy screenings in the mid-1990s the overall incidences for colorectal cancer have been coming down and down and down, and the number of deaths has been going down and down and down,” said Peter Stanich, MD, a James clinical associate professor of internal medicine and colorectal cancer specialist. In this episode, Stanich describes how lifestyle choices such as diet, exercise and obesity can impact the chances of being diagnosed with colorectal cancer. Inherited genetic mutations are another risk factor. “The risk for the average person with no family history [of colorectal cancer] is about 4 percent, but for someone with an inherited genetic mutation, such as Lynch Syndrome, that greatly increases the risk, to as much as 40 to 80 percent,” he said. For people with no family history of colorectal cancer, colonoscopy screenings are recommended to start at the age of 45. “For patients with Lynch syndrome we start screenings at around 20 or 25.” Colonoscopies can detect and remove pre-cancerous polys in the large intestine before they become cancerous. “We have tools that go through the scope, a snare, that can slice off the polyps, or forceps that can cut them off,” said Stanich, who does these procedures regularly. “It's very rewarding, that feeling of helping of helping multiple people every day from ever getting cancer.” Stanich also talked about screenings people can do at home, the increase in colorectal cancer diagnoses for younger patients and his research. It focuses on when to do follow-up screenings for patients detected with multiple polyps in their initial colonoscopy. “Only about 60 percent of people are up to date with their colorectal cancer screenings,” Stanich said. “If we could get another 20 to 30 percent of people up to date that would have a huge impact in reducing colorectal cancer.”

Welcome back to today's Friday Review where I'll be breaking down the best of the week!     I'll be sharing specifics on these topics:     Weekly Podcast Recap Coros Pace 3 vs. Apple Watch (product review) Dostarlimab and Endometrial & Colorectal Cancer (research)   For all the details tune in to today's Cabral Concept 3290 – Enjoy the show and let me know what you thought!   - - - For Everything Mentioned In Today's Show: StephenCabral.com/3290 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!